ArticleBlood cancer journal2012

Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomib.

T Ishii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.